#ExploringMining #Podcast Episode 122 – #Mining #Stock News from (NYSE: $AA) (NasdaqGS: $KALU) (NYSE: $IAG) (NYSE: $EXK) (TSX: $LN.TO)

#ExploringMining #Podcast Episode 122 – #Mining #Stock News from (NYSE: $AA) (NasdaqGS: $KALU) (NYSE: $IAG) (NYSE: $EXK) (TSX: $LN.TO)

 

Point Roberts WA, Delta BC, December 1, 2020 Investorideas.com, a global investor news source covering mining and metals stocks releases today’s edition of Exploring Mining Podcast, featuring stock news from TSX, TSXV ,CSE, ASX, NASDAQ, NYSE  companies plus interviews with CEO's and leading experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/120120-Mining.mp3

 

Read this in full at

https://www.investorideas.com/news/2020/exploring-mining/12011AA-KALU-IAG-EXK-LN.asp

 

Listen to Exploring Mining podcast on iTunes Apple podcasts   

 

Listen to Exploring Mining on Spotify

 

Alcoa Corporation (NYSE:AA) has announced an agreement to sell its rolling mill business to Kaiser Aluminum Corporation (NasdaqGS:KALU) for total consideration of approximately $670 million. The transaction will see Alcoa “retain ownership of the site’s 269,000 metric ton per year aluminum smelter and its electric generating units,” and “enter into a market-based metal supply agreement with Kaiser Aluminum at closing.” Roy Harvey, CEO of Alcoa, said:

 

"The sale will achieve a key target in our strategy to focus on core markets while generating additional cash. We look forward to having Kaiser Aluminum as a valued customer at Warrick Operations, and we thank all of the employees who have contributed significantly to the site’s 60-year history of manufacturing excellence."

 

IAMGOLD Corporation (NYSE:IAG) has reported the remaining assay results from its 2020 exploration diamond drilling program at its Nelligan joint venture project in Quebec, Canada. Craig MacDougall, Executive Vice President, Growth for IAMGOLD, explained:

 

"These remaining results continue to demonstrate continuity of mineralization from the infill drill holes completed in the resource area, and importantly, also continue to demonstrate that mineralization extends well beyond the area of the current modeled resource to the west for at least 500 to 700 metres. The mineralization and associated alteration intersected to date along this western extension appears similar to that observed in the current estimated resource and has potential to expand existing project resources with additional drilling. I must congratulate the exploration team for their perseverance to safely and successfully complete the 2020 exploration program with the numerous challenges posed by the global COVID-19 crisis."

 

Endeavour Silver Corp. (NYSE:EXK) is intersecting high-grade gold-silver mineralization in the Melladito and San Bernabe vein systems at the Bolanitos mine in Guanajuato, Mexico. According to the press release, the site has seen 22 holes drilled, of which, 11 holes and 22 mineralized intervals returned high grades over mineable widths. Highlights include: hole BN-58, which boasted 12.76 gpt gold and 55 gpt silver over 4.5 m true width, featuring 0.4 m grading 43.5 gpt gold and 171 gpt silver, and hole BN-52, which reported 0.51 gpt gold and 491 gpt silver over 2.7 m true width, featuring 0.4 m grading 1.74 gpt gold and 2,220 gpt silver.

 

Loncor Resources Inc. (TSX:LN) has reported multiple gold intercepts at the first core hole of a 7,000 metre drilling program at its flagship Adumbi deposit. This includes “20.33 metres grading 2.47 g/t gold (including 4.8 metres grading 5.40 g/t Au), 7.33 metres grading 5.80 g/t Au and 20.77 metres grading 1.72 g/t Au, on its 84.68% owned Imbo Project,” in the Democratic Republic of the Congo (DRC). Loncor’s President, Peter Cowley, commented:

 

“We are encouraged by the results of this first hole of our 7,000 metre drilling program at Adumbi where we are targeting a significant increase of resources, both within and below the open pit shell. Exploration is also ongoing on new targets along the 14 kilometre long mineralized trend on the Imbo permit in order to generate additional drill targets. If we achieve our objectives, the next step will be a Preliminary Economic Assessment to illustrate the positive economic potential that we believe is contained within Adumbi and the neighbouring deposits and other targets within the Imbo exploitation permit.”

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Research mining stocks at Investorideas.com with our mining stocks directory at Investorideas.com https://www.investorideas.com/Gold_Stocks/Stocks_List.asp 

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com to be a guest or sponsor this podcast

800-665-0411

 

 

Get more mining stock investor ideas- news, articles, podcasts and stock directories

#RareEarth #Mining Media Alert for Defense Metals (TSXV: $DEFN.V) (OTCQB: $DFMTF) – “ DEFENSE METALS, TUI, EVERFUEL - THESE ARE THE NEW STARS!” @DefenseMetals #REE

#RareEarth #Mining Media Alert for Defense Metals (TSXV: $DEFN.V)

(OTCQB: $DFMTF) – “ DEFENSE METALS, TUI, EVERFUEL - THESE ARE THE NEW STARS!” @DefenseMetals #REE

 

Vancouver, British Columbia – Investorideas.com Newswire –Media alert for Defense Metals Corp. (TSX-V: DEFN / OTCQB: DFMTF / FSE: 35D).The company was featured in the following  published article as rare earth metal prices rise in China.  

 

Read this news featuring DEFN in full at https://www.investorideas.com/news/2020/mining/12011Defense-Metals-Tui-Everfuel.asp

 

DEFENSE METALS, TUI, EVERFUEL - THESE ARE THE NEW STARS!

 

DRAMATIC DEVELOPMENT

These scarce raw materials are "rare earth metals." Permanent magnets for electric motors, for example, are produced based on "rare earth metals" - REM. Smartphones, monitors and even wind turbines contain dysprosium, neodymium, germanium or gallium. REMs play a decisive role in the production of weapons. For example, the US Air Force's most modern combat aircraft, the F-35, requires about 1,000 pounds of rare earth metals, most of which are currently sourced from China.

 

CHINA ON THE MOVE

The US is also dependent on China for REMs, needed for laser-guided missiles, other advanced weapon systems and space satellites. And here is the problem, currently 80% of rare earths are produced in China, a quasi-monopoly. Due to the trade dispute with the US, this can lead to enormous supply bottlenecks in the Western world. As early as 2017, outgoing President Trump tried to free the US from its dependence on China for rare earth metals by issuing an Executive Order. This Executive Order was followed with a statement by the President in early October declaring a national state of emergency in the mining sector to set up a US domestic REM storage facility for military requirements.

 

ALTERNATIVE FROM CANADA

The Canadian mineral explorer Defense Metals has its finger on the pulse here. Founded in 2016, the Company focuses on the acquisition of mineral deposits containing metals and elements used in the production of renewable energy technologies, such as rare earth magnets. The main focus is on the Wicheeda project in the province of British Columbia.

 

SUCCESSFUL PLACEMENT

By the end of October, the Canadians were able to complete a private placement of 2,525,000 units for gross proceeds of CAD 505,000. Last week, the private placement of 800,000 shares was announced, which puts another CAD 200,000 in the pockets of Defense Metals. Defense Metals' CEO, Craig Taylor, commented on the use of the funds: "The previously closed 25-cent-per-share private placement financing will be used to conduct additional fill-in hydrometallurgical test work with the objective of capitalizing on opportunities that have been identified to optimize and improve on our already exceptional hydromet recoveries. As previously disclosed, we intend to complete the preliminary economic assessment by the end of the Q1 2021." The market capitalization of the Company is currently CAD 11.24. A bet on the future!**

 

Full article and Original source 

https://news.financial/comments/defense-metals-tui-everfuel-these-are-the-new-stars

 

Recent Company News: November 23-

Defense Metals Corp. Initiates Pre-Pilot Hydrometallurgical Optimization for its Rare Earth Elements Project

 

Defense Metals Corp. (TSX-V: DEFN / OTCQB: DFMTF / FSE: 35D) is pleased to announce that it has commissioned SGS Canada Inc. ("SGS") to complete additional pre-pilot hydrometallurgical test work utilizing high-grade rare earth element (REE) mineral concentrate produced during the Company's highly successful 26 tonne flotation pilot-plant that yielded a mineral concentrate averaging 7.4% NdPr oxide (neodymium-praseodymium) (see Defense Metals news release dated September 23, 2020).

Craig Taylor, CEO comments:

 

"The previously closed $0.25 per share private placement financing will be used to conduct additional fill-in hydrometallurgical test-work with the objective of capitalizing on opportunities that have been identified to optimize and improve on our already exceptional hydromet recoveries. As previously disclosed, we intend to complete the preliminary economic assessment (PEA) by the end of the Q1 2021."

Full news: https://ca.finance.yahoo.com/news/defense-metals-corp-initiates-pre-130000703.html

 

About Defense Metals Corp. https://defensemetals.com/

Defense Metals Corp. is a mineral exploration company focused on the acquisition of mineral deposits containing metals and elements commonly used in the electric power market, military, national security and the production of “GREEN” energy technologies, such as, high strength alloys and rare earth magnets. Defense Metals has an option to acquire 100% of the 1,708 hectare Wicheeda Rare Earth Element Property located near Prince George, British Columbia, Canada. Defense Metals Corp. trades in Canada under the symbol “DEFN” on the TSX Venture Exchange, in the United States, under “DFMTF” on the OTCQB and in Germany on the Frankfurt Exchange under “35D”.

 

For further information, please contact:

Todd Hanas, Bluesky Corporate Communications Ltd.

Vice President, Investor Relations

Tel: (778) 994 8072

Email: todd@blueskycorp.ca

 

Forward Looking Information

This news release contains “forward‐looking information or statements” within the meaning of applicable securities laws, which may include, without limitation, statements relating to finding partnerships, securing potential offtake agreements, and other business opportunities, the technical, financial and business prospects of the Company, its project and other matters. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of rare earth elements, the ability to achieve its goals, that general business and economic conditions will not change in a material adverse manner, that financing will be available if and when needed and on reasonable terms. Such forward-looking information reflects the Company’s views with respect to future events and is subject to risks, uncertainties and assumptions, including those filed under the Company’s profile on SEDAR at www.sedar.com. Factors that could cause actual results to differ materially from those in forward looking statements include, but are not limited to, continued availability of capital and financing and general economic, market or business conditions, adverse weather conditions, failure to maintain all necessary government permits, approvals and authorizations, failure to maintain community acceptance (including First Nations), decrease in the price of rare earth elements, the impact of Covid-19 or other viruses and diseases on the Company’s ability to operate increase in costs, litigation, and failure of counterparties to perform their contractual obligations. The Company does not undertake to update forward‐looking statements or forward‐looking information, except as required by law.

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: this news release featuring Defense Metals Corp. is a paid for service on Investorideas.com ($750) more disclaimer info:

https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

 

 

MiningSectorStocks.com - investing ideas in mining stocks

Like Mining Stocks? View our Mining Stocks Directory  Get News Alerts on Mining Stocks

 

#MedicalTech/ #TherapeuticTechnology #Stock News -Sigyn Therapeutics (OTC: $SIGY) Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines from Human Blood Plasma; @Sigyn_inc

 

#MedicalTech/ #TherapeuticTechnology #Stock News -Sigyn Therapeutics (OTC: $SIGY) Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines from Human Blood Plasma; @Sigyn_inc

 

Sigyn Therapy™ is a Candidate to Treat Sepsis and Other Life-Threatening Inflammatory Conditions That Are Not Addressed with Approved Drugs

 

SAN DIEGO, CA, December 1, 2020 / -(Investorideas.com newswire) Breaking Medical Tech/ therapeutic technology stock news -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on treating life-threatening inflammatory conditions, today announced the completion of an in vitro study that demonstrated the ability of Sigyn Therapy™ to clear both endotoxin and inflammatory cytokines from human blood plasma. 

 

Read this news featuring SIGY in full at https://www.investorideas.com/news/2020/biotech/12011SIGY-Endotoxin-Cytokines.asp

 

Sigyn Therapy is a novel blood purification technology designed to mitigate cytokine storm syndrome, which precipitates a wide-range of life-threatening conditions, including sepsis, the most common cause of hospital deaths.  Virus induced cytokine storm syndrome is associated with high mortality and currently is a leading cause of SARS-CoV-2 (COVID-19) deaths.  Sigyn Therapy is a single-use device designed for use on the established infrastructure of dialysis and CRRT machines located in hospitals and clinics worldwide.

 

In the in vitro study, Sigyn Therapy simultaneously reduced the presence of endotoxin and relevant pro-inflammatory cytokines, which included Interleukin-1 Beta (IL-1B), Interleukin-6 (IL-6) and Tumor Necrosis Factor alpha (TNF-a). Endotoxin (lipopolysaccharide or LPS) is a potent mediator implicated in the pathogenesis of sepsis and septic shock.  The dysregulated over-production of IL-1B, IL-6 and TNF-a can lead to organ failure and cause death.

 

An objective of the study was to rebalance elevated cytokine levels and optimize the elimination of endotoxin from human blood plasma. The study was conducted in triplicate over four-hour time periods with a pediatric version of Sigyn Therapy.  Average reduction of endotoxin load peaked at 83% during the studies. The average reduction of IL-1B was 69%, IL-6 reduction was 59% and TNF-a reduction was 57% during the four-hour studies.  The resulting data will be incorporated into an Investigational Device Exemption (IDE) that Sigyn plans to submit to the United States Food and Drug Administration (FDA) in 2021.

 

“The simultaneous clearance of endotoxin and inflammatory cytokines is a significant milestone that reinforces the potential of Sigyn Therapy to overcome the limitations of industry pioneering devices that are currently deployed to treat life-threatening inflammatory conditions,” stated Jim Joyce, Chairman and CEO of Sigyn Therapeutics.

 

At present, the CytoSorb device from CytoSorbents Corporation and the Toraymyxin device from Toray Industries are market cleared and broadly administered to treat a wide-range of life-threatening inflammatory conditions outside of the United States. In regards to mechanism, the Toraymyxin device has a high specificity to bind circulating endotoxin, but does not address inflammatory cytokines. Conversely, the CytoSorb device depletes inflammatory cytokines from circulation, but does not address endotoxin.

 

In addition to reporting the dual clearance of endotoxin and inflammatory cytokines, the Company further disclosed that it plans to evaluate the ability of Sigyn Therapy to address other inflammatory targets, including CytoVesicles that transport inflammatory cytokine cargos throughout the bloodstream.  The Company believes that Sigyn Therapy is the first therapeutic candidate to target circulating CytoVesicles.

 

About Sigyn Therapeutics

Sigyn Therapeutics™ is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

 

Sigyn Therapy™ is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.

 

To learn more, visit www.SigynTherapeutics.com  or www.SigynTherapy.com

 

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements of Sigyn Therapeutics, Inc. (“Sigyn”) that involve substantial risks and uncertainties. All statements contained in this press release are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words “could,” “will,” “plan,” “intend,” “anticipate,” “approximate,” “expect,” “potential,” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among others, statements about Sigyn’s future financial performance, the impact of management changes, any proposed organizational restructuring, results of operations, capital resources to fund operations; statements about Sigyn’s expectations regarding the capitalization, resources and ownership structure of the combined company; statements about the potential benefits of the transaction; the expected completion and timing of the transaction and other information relating to the transaction; and any other statements other than statements of historical fact. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that Sigyn makes due to a number of important factors, including (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect Sigyn’s business and the price of the common stock of Sigyn, (ii) the failure to satisfy of the conditions to the consummation of the transaction, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (iv) risks related to the ability to realize the anticipated benefits of the transaction, including the risk that the businesses will not be integrated successfully, (v) the effect of the announcement or pendency of the transaction on Sigyn’s business relationships, operating results and business generally, (vi) risks that the proposed transaction disrupts current plans and operations, (vii) risks related to the combined entity’s ability to up-list to a national securities exchange, (viii) risks related to the combined entity’s access to existing capital and fundraising prospects to fund its ongoing operations, (ix) risks related to diverting management’s attention from Sigyn’s ongoing business operations, (x) other business effects, including the effects of industry, market, economic, political or regulatory conditions, future exchange and interest rates, and changes in tax and other laws, regulations, rates and policies, and (xi) risks related to an inability to manufacture Sigyn Therapy, risks related to the clinical advancement of Sigyn Therapy with regulatory agencies, and no assurance that Sigyn Therapy will be proven to be a safe and efficacious treatment for any condition. The forward-looking statements in this press release represent Sigyn’s views as of the date of this press release. Sigyn anticipates that subsequent events and developments may cause its views to change. However, while it may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. You should, therefore, not rely on these forward-looking statements as representing Sigyn’s views as of any date subsequent to the date of this press release.

 

Contact Sigyn Therapeutics, Inc.

Jim Joyce

Chairman, CEO

(619) 368-2000

jimjoyce@elevatescience.com

 

Investorideas.com Paid news Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure : this news release featuring (OTCMARKETS: SIGY) is a paid for news release on Investorideas.com  https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on Investorideas.com

 

 

 

 

 

#AI #Stock News: GBT (OTCPINK: $GTCH) Tokenize Open Public Research Kirlian Electrophotography: @GbtTechnologies #artificialintelligence

#AI #Stock News: GBT (OTCPINK: $GTCH) Tokenize Open Public Research Kirlian Electrophotography: @GbtTechnologies #artificialintelligence

 

SAN DIEGO - December 1, 2020 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company"), announced as a further update to its press release issued November 12, 2020, that GBT Tokenize ("GBT/Tokenize"), its joint venture, started Phase I in the Kirlian Electrophotography imaging technique, potentially aimed for inclusion within its qTerm device. Kirlian photography is a series of techniques that are based on the phenomenon known as electrical coronal discharge. Images that are taken using these techniques present a colorful so-called aura, which can be interpreted in a variety of ways.

 

Read this news featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2020/12011Kirlian-Electrophotography.asp

 

 

Phase 1 : Hand image

 

Phase 1 : Body image

 

Phase 1 : Body image - test3

 

Phase I Update - Techniques Research

The open research is focused on the efforts combining Kirlian imaging with the use of machine learning technology to possibly detect early disease symptoms. GBT/Tokenize is conducting experiments with a few advanced algorithms, one of them is a private derivative of the Genetic algorithm. The genetic algorithm is a method for solving both constrained and unconstrained optimization problems that are based on natural selection, the process that drives biological evolution. The algorithm is planned to find pattern similarities in Kirlian images in living tissues in order to categorize potential health related issues. Kirlian imaging produces typical features such as graphical protuberances, halos, and discharge patterns, which can be analyzed by an AI computer program as unique patterns, and categorized as possible criteria for early symptoms identification. GBT/Tokenize is conducting experiments with advanced algorithms and methods to analyze energy fields generated by living organs at set periods. These image's auras will be graphically analyzed to determine patterns that are associated with possible health related symptoms. GBT/Tokenize plans to develop neural network based pattern recognition technology to detect-and-associate unique patterns with related, possible health issues. The research is planned to be conducted over a period of one year and based on its results the company will evaluate the feasibility of implementation of such techniques within its qTerm human vitals product in order to provide further health information for the user's benefit.

 

"We are going to look deeper into Kirilian electrophotography science, trying to identify the possibility of detecting early disease symptoms. Kirlian images of a living tissue during various intervals may exhibit some similarities. If we could graphically analyze these images using machine learning technology, reaching some consistent conclusions, then we may find a way to find possible early health issue identification" stated Danny Rittman, GBT’s CTO.

 

"We intend to analyze and measure Kirilian images to find unique patterns that may be associated with early symptoms. We will look for full and partial similarities, repetitions, or atypical auras patterns. We will be using AI computing power to detect dynamic images changes as each image will be digitized using high resolution scanning. Here the power of huge data analysis will be extremely beneficial. We plan to implement interactive algorithms to analyze on-the-fly out-of-boundaries patterns to get a comparative representation between the images. The challenging part will be to associate the human body's various radiations graphical representation, with health related issues. For this purpose, we plan to use our AI, vast data analysis capabilities, trying to assemble a reliable algorithm to create an associative table that will relate patterns to a possible onset disease. Upon reaching conclusions we will evaluate the potential implementation of this technology within our qTerm device to further advice users about their health” continued Dr. Rittman.

 

Actual GBT/Tokenize’s Phase I imaging (for presentation purposes only) are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/475d6f41-3737-40c8-b83e-89cf23d2f1d3

 

https://www.globenewswire.com/NewsRoom/AttachmentNg/6d35d0f1-1c13-4993-8c7c-a44c3cc20f00

 

https://www.globenewswire.com/NewsRoom/AttachmentNg/7e4996dd-94b8-46cf-a6a7-144b5c3570c8

 

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms. GBT has a portfolio of Intellectual Property that, if commercialized, is designed to include smart microchips, mobile and security applications and protocols and supporting cloud software. GBT's system envisions the creation of a global mesh network. The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
GBT Technologies Inc.
Media: press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories